Earlier quoted context omitted.
>I think this is partly out of ethical standards (yes, CEO's, even pharma CEO's, can possess this) Not buying it. I'll buy the fallout argument, as that will hurt them monetarily, but I'm not guying them have any moral or ethical concerns with those being hurt by high drug prices.
What's more ethically questionable: spending billions in capital developing drugs to save lives, and trying to make money off that, or spending billions of capital on endeavors like entertainment services that don't save lives at all?
When J&J sells an antipsychotic with bad side-effects for off-label uses in contravention of an order not to, that's worth about 100,000 Justin Biebers.